Fetching the paper…
Reading the bibliography…
The rapid digitization of real-world data presents an unprecedented opportunity to optimize healthcare delivery and accelerate biomedical discovery.
“Regression Models and Life Tables”
D Cox · 1972
Earlier work this paper cites.
“The central role of the propensity score in observational studies for causal effects”
Paul Rosenbaum and Donald Rubin · 1983
Earlier work this paper cites.
“Adjusted survival curves with inverse probability weights”
Stephen. Cole and Miguel. Hernán · 2003
Earlier work this paper cites.
“Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?”
Debbie. Lawlor et al · 2004
Earlier work this paper cites.
“The Central Role of the Propensity Score in Observational Studies for Causal Effects”
Paul. Rosenbaum and Donald. Rubin · 2006
Earlier work this paper cites.
“Utility of administrative claims data for the study of brain metastases: a validation study”
April. Eichler and Elizabeth. Lamont · 2009
Earlier work this paper cites.
“The hazards of hazard ratios” Erratum in: Epidemiology. 2011 Jan;22(1):134. PMID: 20010207; PMCID: PMC3653612
MA Hernán · 2010
Earlier work this paper cites.
“Deming, data and observational studies”
S. Young and Alan Karr · 2011
Earlier work this paper cites.
“Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine”
Daniel. Von et al · 2013
Earlier work this paper cites.
“ICD-9 tobacco use codes are effective identifiers of smoking status”
Laura Wiley, Anushi Shah and Hua. Xu · 2013
Earlier work this paper cites.
“A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results”
T. Kennedy-Martin et al · 2015
Earlier work this paper cites.
“The Extent and Consequences of P-Hacking in Science”
Megan. Head et al · 2015
Earlier work this paper cites.
“Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction”
Guido. Imbens and Donald. Rubin · 2015
Earlier work this paper cites.
“Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available”
Miguel. Hernan and James. Robins · 2016
Earlier work this paper cites.
“Comparison of Three Information Sources for Smoking Information in Electronic Health Records”
Liwei Wang, Xiaoyang Ruan, Ping Yang and Hongfang Liu · 2016
Earlier work this paper cites.
“From Scientific Discovery to Treatments for Rare Diseases – The View from the National Center for Advancing Translational Sciences – Office of Rare Diseases Research”
Petra Kaufmann, Anne. Pariser and Christopher Austin · 2018
Earlier work this paper cites.
“Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database”
P. Agarwal et al · 2018
Earlier work this paper cites.
“Real-world evidence of male breast cancer (BC) patients treated with palbociclib (PAL) in combination with endocrine therapy (ET)”
C.. Bartlett, J. Mardekian, M. Yu-Kite and et al · 2019
Earlier work this paper cites.
“Biomarker-Driven Oncology Clinical Trials: Key Design Elements, Types, Features, and Practical Considerations”
Chen Hu and James. Dignam · 2019
Cited alongside, same era.
“MIWAE: Deep Generative Modelling and Imputation of Incomplete Data Sets”
Pierre-Alexandre Mattei and Jes Frellsen · 2019
Cited alongside, same era.
“Benefits and limitations of real-world evidence: lessons from EGFR mutation-positive non-small-cell lung cancer”
Bassel Nazha, James-Hsin Yang and Taofeek. Owonikoko · 2020
Cited alongside, same era.
“Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study”
Martijn. Schuemie, Patrick. Ryan, Nicole Pratt and et al · 2020
Cited alongside, same era.
“Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND)”
Martijn. Schuemie, Patrick. Ryan, Nicole Pratt and et al · 2020
Cited alongside, same era.
“An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review”
Weilin Meng et al · 2021
Later among the works it cites.
“Real-World Evidence — Where Are We Now?”
John Concato and Jacqueline Corrigan-Curay · 2022
Later among the works it cites.
“Real world evidence framework”, 2022
National Institute for Health and Care Excellence · 2022
Later among the works it cites.
“Real-world data: a brief review of the methods, applications, challenges and opportunities”
Fang Liu and Demosthenes Panagiotakos · 2022
Later among the works it cites.
“Randomized trials and their observational emulations: a framework for benchmarking and joint analysis”
Issa. Dahabreh, Jon. Steingrimsson, James. Robins and Miguel. Hernán · 2022
Later among the works it cites.
alphaXiv searches the wider corpus for related work and actual follow-ups.
alphaXiv is searching for related work…
“What’s the Risk: Differentiating Risk Ratios, Odds Ratios, and Hazard Ratios?”
Andrew George, Thor Stead and Latha Ganti · 2020
Cited alongside, same era.
“How Confident Are We about Observational Findings in Healthcare: A Benchmark Study”
MJ Schuemie et al · 2020
Cited alongside, same era.
“Characterization of Overlap in Observational Studies”
M Oberst et al · 2020
Cited alongside, same era.
“DoWhy: An End-to-End Library for Causal Inference”
Amit Sharma and Emre Kiciman · 2020
Cited alongside, same era.
“Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimer’s disease”
Zhe Chen et al · 2021
Cited alongside, same era.
“Improving diversity in medical research”
A. Sharma and L. Palaniappan · 2021
Cited alongside, same era.
“Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study”
B. Fritzsching, M. Contoli, C. Porsbjerg and et al · 2021
Cited alongside, same era.
Rachel Axelrod and Daniel Nevo · 2022
Later among the works it cites.
“Multi-Disciplinary Fairness Considerations in Machine Learning for Clinical Trials”
Isabel Chien et al · 2022
Later among the works it cites.
“Top ten largest health systems in the US by number of hospitals affiliated”, 2022
hospitalmanagement · 2022
Later among the works it cites.
“Towards Structuring Real-World Data at Scale: Deep Learning for Extracting Key Oncology Information from Clinical Text with Patient-Level Supervision”
Sam Preston et al · 2022
Later among the works it cites.
“Uncovering interpretable potential confounders in electronic medical records”
Jiaming Zeng et al · 2022
Later among the works it cites.
“Clinico-Genomic Database (CGDB)”, 2023
Flatiron Health · 2023
Closest in time.
“Toward structuring real-world data: Deep learning for extracting oncology information from clinical text with patient-level supervision”
Sam Preston et al · 2023
Closest in time.
“Quality Assurance and Technology-Enabled Curation of Oncology Real-World Data: The Importance of Individual Quality Reviews”
Katherine Levie et al · 2023
Closest in time.
OpenAI · 2023
Closest in time.
“Scaling Clinical Trial Matching Using Large Language Models: A Case Study in Oncology”
Cliff Wong et al · 2023
Closest in time.
“Advancing Real-World Evidence Program”, 2024
U.S. Food and Drug Administration · 2024
Closest in time.
“How AI is being used to accelerate clinical trials”
Matthew Hutson · 2024
Closest in time.
“Matching patients to clinical trials with large language models”
Qian Jin et al · 2024
Closest in time.